Certificate of Advanced Study in Pharmaceutical Organization and Processes, terminato il terzo modulo 2 Luglio 2015
TGA Approves AKYNZEO® (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) 20 Maggio 2015
Terminato il secondo dei quattro moduli della seconda edizione del corso di formazione FIT 22 Aprile 2015
Helsinn Group Signs Exclusive Agreement with Mundipharma for Distribution and Licence of Anamorelin in China, Hong Kong and Macao 27 Marzo 2015
Helsinn Group signs exclusive agreements with Mundipharma for distribution and licence of anamorelin in Brazil and across key markets in the Middle East and North Africa 11 Febbraio 2015
Helsinn Group signs exclusive agreement with Mundipharma for distribution and licensing of Netupitant/Palonosetron (nepa) in Brazil 10 Febbraio 2015
Linkedin